BIOMAT Database Logo BIOMAT Database Logo

Angiotensin infusion test in arterial hypertension. 1966

B Weeke, and A R Krogsgaard

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

B Weeke, and A R Krogsgaard
Angiotensin infusion test in hypertension.
May 1966, American heart journal,
B Weeke, and A R Krogsgaard
[Angiotension infusion test in arterial hypertension].
April 1966, Ugeskrift for laeger,
B Weeke, and A R Krogsgaard
[Intravenous infusion of angiotensin for the diagnosis of arterial hypertension (Kaplan-Silah test)].
April 1969, Polski tygodnik lekarski (Warsaw, Poland : 1960),
B Weeke, and A R Krogsgaard
THE ANGIOTENSIN INFUSION TEST FOR RENOVASCULAR HYPERTENSION.
March 1965, Connecticut medicine,
B Weeke, and A R Krogsgaard
[Diagnostic value of the Kaplan-Silah angiotensin infusion test in arterial hypertension of various etiology].
February 1970, Polski tygodnik lekarski (Warsaw, Poland : 1960),
B Weeke, and A R Krogsgaard
[Value of the Kaplan-Silah angiotensin infusion test in the etiologic diagnosis of arterial hypertension].
April 1968, Il Policlinico. Sezione pratica,
B Weeke, and A R Krogsgaard
Angiotensin infusion test in the diagnosis of renal hypertension.
April 1974, The Journal of the Association of Physicians of India,
B Weeke, and A R Krogsgaard
[Angiotensin-infusion test in the diagnosis of renovascular hypertension].
April 1969, Polskie Archiwum Medycyny Wewnetrznej,
B Weeke, and A R Krogsgaard
[Exploration of arterial hypertension by the angiotensin test].
December 1965, Archives des maladies du coeur et des vaisseaux,
B Weeke, and A R Krogsgaard
Angiotensin infusion test.
January 1968, Canadian Medical Association journal,
Copied contents to your clipboard!